National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Primary CNS Lymphoma Treatment (PDQ®)     
Last Modified: 02/06/2008
Health Professional Version
Changes to This Summary (02/06/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information 1

Added text 2 to the list of poor prognostic factors to include age older than 50 years and Karnosky performance status less than 70 (cited Abrey et al. as reference 5).

Treatment Option Overview 3

Added Colombat et al. as reference 26 4.


Table of Links

1http://cancer.gov/cancertopics/pdq/treatment/primary-CNS-lymphoma/HealthProfess
ional/1.cdr#Section_1
2http://cancer.gov/cancertopics/pdq/treatment/primary-CNS-lymphoma/HealthProfess
ional/19.cdr#Section_19
3http://cancer.gov/cancertopics/pdq/treatment/primary-CNS-lymphoma/HealthProfess
ional/9.cdr#Section_9
4http://cancer.gov/cancertopics/pdq/treatment/primary-CNS-lymphoma/HealthProfess
ional/6.cdr#Section_6